Dr. Barry Byrne is a clinician scientist who is studying a variety of rare diseases with the specific goal ofdeveloping therapies for inherited muscle disease. As a pediatric cardiologist, his focus is on conditions thatlead to skeletal muscle weakness and abnormalities in heart and respiratory function.  His group has madesignificant contributions to the understanding and treatment of Pompe disease, a type of neuromusculardisease due to glycogen storage in motor units.  The research team has been developing new therapies usingAAV-mediated gene therapy to restore cardiac and skeletal muscle function in DMD, LGMD, Friedreich’s ataxia, Pompe, and other inherited neuromuscular diseases. His group at the Powell Gene Therapy Centerhas also established a series of new methods for large-scale AAV clinical manufacturing. The work issupported by several NIH, industry and foundation awards.

Dr. Byrne is the Associate Chair of Pediatrics and Director of the University of Florida Powell Gene Therapy Center and Child Health Research Institute. He is also the Director of UF Health Center for Advanced Therapeutics. He obtained his B.S. degree from Denison University; M.D. and Ph.D. from the University ofIllinois; and he completed his Pediatrics residency and cardiology fellowship as well as post-doctoral training in Biological Chemistry at the Johns Hopkins Hospital.  Following his early career at Hopkins, he joined the University of Florida and is now the Earl and Christy Powell University Chair in Genetics.

In addition to his academic appointments, he serves as the Chief Medical Advisor and a member of the Board of Directors of the Muscular Dystrophy Association.